Team:Virtus-Parva Mexico/Safety
From 2014.igem.org
Line 97: | Line 97: | ||
<br> | <br> | ||
<p align="justify"><font size=4 color="#ffffff"> | <p align="justify"><font size=4 color="#ffffff"> | ||
- | Question 1: Would any of your project idea raise safety <br> | + | <i>Question 1: Would any of your project idea raise safety <br> |
issues in terms of research safety, public safety or <br> | issues in terms of research safety, public safety or <br> | ||
- | environmental safety?<br> | + | environmental safety?</i><br> |
<br> | <br> | ||
The strain of E. Coli we chose to work with, DSM <br> | The strain of E. Coli we chose to work with, DSM <br> | ||
Line 114: | Line 114: | ||
<br> | <br> | ||
<br> | <br> | ||
- | Question 2: Are any parts or devices in our project <br> | + | <i>Question 2: Are any parts or devices in our project <br> |
associated with (or known to cause) pathogenicity, <br> | associated with (or known to cause) pathogenicity, <br> | ||
infectivity, toxicity, threats to environmental quality<br> | infectivity, toxicity, threats to environmental quality<br> | ||
- | or security concerns? | + | or security concerns?</i> |
<br> | <br> | ||
The biggest risk comes from E. Coli infections to our <br> | The biggest risk comes from E. Coli infections to our <br> |
Revision as of 02:43, 18 October 2014
|
Our Questions
Question 1: Would any of your project idea raise safety |
|
|